To evaluate the influence of FSCN1 downregulation among the various cellular effects mediated by miR‐143‐3p and miR‐145‐5p, we then performed a loss‐of‐function experiment using FSCN1‐specific siRNAs in BRAF‐mutant parental melanoma cells. The gene discussed is BRAF; the disease is melanoma.